Omega Fund Management as of March 31, 2017
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 11 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Paratek Pharmaceuticals | 32.5 | $50M | 2.6M | 19.25 | |
| Juno Therapeutics | 17.7 | $27M | 1.2M | 22.19 | |
| Fibrogen (FGEN) | 13.0 | $20M | 813k | 24.65 | |
| Egalet | 9.6 | $15M | 2.9M | 5.10 | |
| Nabriva Therapeutics | 8.9 | $14M | 1.1M | 12.00 | |
| Jounce Therapeutics | 8.3 | $13M | 580k | 21.99 | |
| Essa Pharma | 3.4 | $5.3M | 1.7M | 3.12 | |
| Pieris Pharmaceuticals | 2.9 | $4.4M | 1.7M | 2.60 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 2.3 | $3.5M | 445k | 7.80 | |
| Cymabay Therapeutics | 0.8 | $1.3M | 302k | 4.30 | |
| Dicerna Pharmaceuticals | 0.5 | $760k | 224k | 3.40 |
